EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 40 / No 3 (September 2008) J Extra Corpor Technol, 40 3 (2008) 206-214 References
Free Access
Issue
J Extra Corpor Technol
Volume 40, Number 3, September 2008
Page(s) 206 - 214
DOI https://doi.org/10.1051/ject/200840206
Published online 15 September 2008
  1. Kwok ESH, Howes D. Use of methylene blue in sepsis: a systematic review. J Intensive Care Med. 2006;21:359–63. [CrossRef] [PubMed] [Google Scholar]
  2. Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29:1860–7. [CrossRef] [PubMed] [Google Scholar]
  3. Donati A, Conti G, Loggi S, et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med. 2002;30:2271–7. [CrossRef] [PubMed] [Google Scholar]
  4. Beasley J, McGuiggin M. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J Exp Med. 1994;179:71–80. [CrossRef] [PubMed] [Google Scholar]
  5. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61:1714–20. [CrossRef] [Google Scholar]
  6. Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116:973–80. [CrossRef] [Google Scholar]
  7. Maslow A, Stearns G, Batula P, et al. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006;103:2–8. [CrossRef] [PubMed] [Google Scholar]
  8. Gomes W, Carvalho AC, Palma JH, et al. Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg (Torino). 1998;39:619–23. [PubMed] [Google Scholar]
  9. Levin R, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77:496–9. [CrossRef] [Google Scholar]
  10. Mekontso-Dessap A, Houël R, Soustelle C, et al. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg. 2001;71:1428–32. [CrossRef] [Google Scholar]
  11. Shanmugan G. Vasoplegic syndrome-the role of methylene blue. Eur J Cardiothorac Surg. 2005;28:705–10. [CrossRef] [Google Scholar]
  12. O’Dwyer C, Woodson LC, Conroy BP, et al. Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg. 1997;63:728–35. [CrossRef] [Google Scholar]
  13. Özal E, Kuralay E, Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79:1615–9. [CrossRef] [Google Scholar]
  14. Yiu P, Robin J, Pattison W. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 1999;118:195–6. [CrossRef] [Google Scholar]
  15. Pagni S, Austin EH. Use of methylene blue for the treatment of refractory hypotension after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2000;119:1–3. [Google Scholar]
  16. Kofidis T, Struber M, Wilhelmi M, et al. Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation. J Thorac Cardiovasc Surg. 2001;122:823–4. [CrossRef] [Google Scholar]
  17. Grayling M, Deakin CD. Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis. J Thorac Cardiovasc Surg. 2003;125:426–7. [CrossRef] [Google Scholar]
  18. Viaro F, Marcelo B, Evora PR. Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated. Should methylene blue be the treatment of choice? Chest. 2002;122:1061–6. [CrossRef] [PubMed] [Google Scholar]
  19. Sheth SS, Del Duca D, Ergina P, Clarke AE. Methylene blue as a treatment for refractory anaphylaxis. J Allergy Clin Immunol. 2007;119:S33. [CrossRef] [Google Scholar]
  20. Evora PR, Oliveira Neto AM, Duarte NM, et al. Methylene blue as treatment for contrast medium-induced anaphylaxis. J Postgrad Med. 2002;48:327. [Google Scholar]
  21. Evora PR, Roselino C, Schiaveto P. Methylene blue in anaphylactic shock. Ann Emerg Med. 1997;30:240. [Google Scholar]
  22. Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002;30:755–62. [CrossRef] [PubMed] [Google Scholar]
  23. Ghiassi S, Sun YS, Kim VB, et al. Methylene blue enhancement of resuscitation after refractory hemorrhagic shock. J Trauma. 2004;57:515–21. [CrossRef] [PubMed] [Google Scholar]
  24. Galili Y, Ben-Abraham R, Weinbroum A, et al. Methylene blue prevents pulmonary injury after intestinal ischemia-reperfusion. J Trauma. 1998;45:222–6. [CrossRef] [PubMed] [Google Scholar]
  25. Dewachter P, Mouton-Faivre C, Tréchot P, Lleu JC, Mertes PM. Severe anaphylactic shock with methylene blue instillation. Anesth Analg. 2005;101:149–50. [CrossRef] [PubMed] [Google Scholar]
  26. Foltz LM, Dalal BI, Wadsworth LD, et al. Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine. Am J Hematol. 2006;81:210–1. [CrossRef] [PubMed] [Google Scholar]
  27. Khanduri U, Sharma A, Kumar P. Unique red cell abnormality in a case of fatal methylene blue induced haemolysis. Hematology. 2004;9:239–41. [CrossRef] [PubMed] [Google Scholar]
  28. Sweet G, Standiford SB. Methylene-blue-associated encephalopathy. J Am Coll Surg. 2007;204:454–8. [CrossRef] [PubMed] [Google Scholar]
  29. McEvoy GK. AHFS Drug Information. American Society of Health-System Pharmacists Available at: http://online.statref.com/document.aspx?.fxid?.1&docid?.1208. Accessed June 11, 2007. [Google Scholar]
  30. Thompson Healthcare. Methylene blue. Micromedex Healthcare Series. Drugdex Evaluations. [Google Scholar]
  31. Morales D, Gregg D, Helman D, et al. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg. 2000;69:102–6. [CrossRef] [Google Scholar]
  32. Dünser M, Mayr A, Ulmer H, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313–9. [CrossRef] [PubMed] [Google Scholar]
  33. Kirlangitis JJ, Middaugh RE, Zablocki A, Rodriguez F. False indication of arterial oxygen desaturation and methemoglobinemia following injection of methylene blue in urological surgery. Mil Med. 1990;155:260–2. [CrossRef] [PubMed] [Google Scholar]
  34. Howland M. Goldfrank’s Toxicologic Emergencies. 8th ed. McGraw-Hill Companies, New York; 2006. [Google Scholar]
  35. Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005;51:434–44. [CrossRef] [PubMed] [Google Scholar]
  36. Price D. Goldfrank’s Toxicologic Emergencies. 8th ed. McGraw-Hill Companies, New York; 2006. [Google Scholar]
  37. LeClaire A, Mullett TW, Jahania MS, Flynn JD. Methemoglobinemia secondary to topical Benzocaine use in a lung transplant patient. Ann Pharmacother. 2005;39:373–6. [CrossRef] [PubMed] [Google Scholar]
  38. Gourlain H, Buneaux F, Borron SW, Gouget B, Levillain P. Interference of methylene blue with CO-oximetry of hemoglobin derivatives. Clin Chem. 1997;43:1078–80. [CrossRef] [PubMed] [Google Scholar]
  39. Kessler MR, Eide T, Humayun B, Poppers PJ. Spurious pulse oximeter desaturation with methylene blue injection. Anesthesiology. 1986;65:435–6. [CrossRef] [PubMed] [Google Scholar]
  40. Matisoff J, Panni MK. Methylene blue treatment for methemoglobinemia and subsequent dramatic bispectral index reduction. Anesthesiology. 2006;105:228. [CrossRef] [PubMed] [Google Scholar]
  41. Mittnacht AJC, Fischer GW, Reich DL. Methylene blue administration is associated with decreased cerebral oximetry values. Anesth Analg. 2007;105:228. [CrossRef] [PubMed] [Google Scholar]
  42. Armstrong D, Schmalfuss V, Reed CC, Stafford TB, McInnis RJ, Thompson DJ. A case study: methemoglobinemia during cardiopulmonary bypass. Proc Am Acad Cardiovasc Perfusion. 1985;6:179–81. [Google Scholar]
  43. Bojar RM, Rastegar H, Payne DD, et al. Methemoglobinemia from intravenous nitroglycerin: a word of caution. Ann Thorac Surg. 1987;43:332–4. [CrossRef] [Google Scholar]
  44. Information on Adverse Event Reports and Heparin. Rockville, MD: Food and Drug Administration; 2008. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.